Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    aTyr Pharma Inc.

    NASDAQ: ATYR · Real-Time Price · USD
    5.20
    -0.23 (-4.24%)
    At close: Jun 13, 2025, 3:59 PM
    5.21
    0.19%
    After-hours: Jun 13, 2025, 07:56 PM EDT

    aTyr Pharma Statistics

    Share Statistics

    aTyr Pharma has 89M shares outstanding. The number of shares has increased by 28.76% in one year.

    Shares Outstanding

    n/a
    		 89M

    Shares Change (YoY)

    n/a
    		 28.76%

    Shares Change (QoQ)

    n/a
    		 5.86%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 86.06M

    Failed to Deliver (FTD) Shares

    n/a
    		 15

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    The latest short interest is 13.77M, so 15.47% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 13.77M

    Short % of Shares Out

    n/a
    		 15.47%

    Short % of Float

    n/a
    		 18.88%

    Short Ratio (days to cover)

    n/a
    		 8.24

    Valuation Ratios

    The PE ratio is -4.2 and the forward PE ratio is -8.93. aTyr Pharma's PEG ratio is 0.49.

    PE Ratio

    n/a
    		 -4.2

    Forward PE

    n/a
    		 -8.93

    PS Ratio

    n/a
    		 1143.94

    Forward PS

    n/a
    		 0.9

    PB Ratio

    n/a
    		 3.84

    P/FCF Ratio

    n/a
    		 -3.89

    PEG Ratio

    n/a
    		 0.49
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for aTyr Pharma.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 5.48, with a Debt / Equity ratio of 0.19.

    Current Ratio

    n/a
    		 5.48

    Quick Ratio

    n/a
    		 5.48

    Debt / Equity

    n/a
    		 0.19

    Debt / EBITDA

    n/a
    		 -0.2

    Debt / FCF

    n/a
    		 -0.19

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $4,196.43

    Profits Per Employee

    n/a
    		 $-1,143,267.86

    Employee Count

    n/a
    		 56

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by 184.15% in the last 52 weeks. The beta is 0.87, so aTyr Pharma's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.87

    52-Week Price Change

    n/a
    		 184.15%

    50-Day Moving Average

    n/a
    		 3.73

    200-Day Moving Average

    n/a
    		 3.24

    Relative Strength Index (RSI)

    n/a
    		 67.36

    Average Volume (20 Days)

    n/a
    		 1,626,473

    Income Statement

    In the last 12 months, aTyr Pharma had revenue of 235K and earned -64.02M in profits. Earnings per share was -0.86.

    Revenue

    n/a
    		 235K

    Gross Profit

    n/a
    		 -1.3M

    Operating Income

    n/a
    		 -67.91M

    Net Income

    n/a
    		 -64.02M

    EBITDA

    n/a
    		 -66.37M

    EBIT

    n/a
    		 -67.91M

    Earnings Per Share (EPS)

    n/a
    		 -0.86
    Full Income Statement

    Balance Sheet

    The company has 11.05M in cash and 13.28M in debt, giving a net cash position of -2.23M.

    Cash & Cash Equivalents

    n/a
    		 11.05M

    Total Debt

    n/a
    		 13.28M

    Net Cash

    n/a
    		 -2.23M

    Retained Earnings

    n/a
    		 -532.05M

    Total Assets

    n/a
    		 97.25M

    Working Capital

    n/a
    		 72.59M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -69.12M and capital expenditures -65K, giving a free cash flow of -69.18M.

    Operating Cash Flow

    n/a
    		 -69.12M

    Capital Expenditures

    n/a
    		 -65K

    Free Cash Flow

    n/a
    		 -69.18M

    FCF Per Share

    n/a
    		 -0.93
    Full Cash Flow Statement

    Margins

    Gross margin is -555.32%, with operating and profit margins of -28899.57% and -27243.83%.

    Gross Margin

    n/a
    		 -555.32%

    Operating Margin

    n/a
    		 -28899.57%

    Pretax Margin

    n/a
    		 -27243.4%

    Profit Margin

    n/a
    		 -27243.83%

    EBITDA Margin

    n/a
    		 -28244.26%

    EBIT Margin

    n/a
    		 -28899.57%

    FCF Margin

    n/a
    		 -29440%

    Dividends & Yields

    ATYR does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for ATYR is $16, which is 207.7% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $16

    Price Target Difference

    n/a
    		 207.7%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 6
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Jul 1, 2019. It was a backward split with a ratio of 1:14.

    Last Split Date

    n/a
    		 Jul 1, 2019

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:14

    Scores

    Altman Z-Score

    n/a
    		 0.77

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist